Analyst Activity – William Blair Reiterates Outperform on Atara Biotherapeutics (NASDAQ:ATRA)

Analyst Ratings For Atara Biotherapeutics (NASDAQ:ATRA)

Story continues below

Today, William Blair reiterated its Outperform rating on Atara Biotherapeutics (NASDAQ:ATRA).

Some recent analyst ratings include

  • 3/20/2018-William Blair Reiterated Rating of Outperform.
  • 3/15/2018-Guggenheim initiated coverage with a Neutral rating.
  • 3/13/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 2/28/2018-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ” rating to a ” Market Perform” rating.
  • 2/15/2018-Citigroup was Downgraded by analysts at Citigroup from a “Neutral ” rating to a ” Sell” rating.
  • 1/26/2018-Cowen initiated coverage with a Outperform rating.

Recent Insider Trading Activity For Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 76.88%.

  • On 3/16/2018 Isaac E Ciechanover, CEO, sold 8,800 with an average share price of $42.13 per share and the total transaction amounting to $370,744.00.
  • On 3/12/2018 Isaac E Ciechanover, CEO, sold 1,000 with an average share price of $46.31 per share and the total transaction amounting to $46,310.00.
  • On 2/22/2018 Isaac E Ciechanover, CEO, sold 17,800 with an average share price of $44.65 per share and the total transaction amounting to $794,770.00.
  • On 2/20/2018 Isaac E Ciechanover, CEO, sold 8,700 with an average share price of $45.28 per share and the total transaction amounting to $393,936.00.
  • On 2/16/2018 Carol Giltner Gallagher, Director, sold 1,183 with an average share price of $46.50 per share and the total transaction amounting to $55,009.50.
  • On 2/16/2018 Isaac E Ciechanover, CEO, sold 20,000 with an average share price of $46.92 per share and the total transaction amounting to $938,400.00.
  • On 2/16/2018 John Mcgrath, CFO, sold 13,000 with an average share price of $47.07 per share and the total transaction amounting to $611,910.00.

Recent Trading Activity for Atara Biotherapeutics (NASDAQ:ATRA)
Shares of Atara Biotherapeutics closed the previous trading session at 39.00 up +0.33 0.84% with shares trading hands.

An ad to help with our costs